Investec has retained its ‘Buy’ recommendation for the £2.5bn Hipgnosis Songs fund following the release of its FY23 results, but noted that “drastic actions” are required ahead of its five-year continuation vote in September.
The move follows the announcement on Thursday (13 July) that the fund was considering strategic options, which may include the potential strategic sale of catalogues of songs, to narrow its deep discount to NAV. The London-listed investment trust, which launched in 2018, is currently trading at a 54.5% discount, according to data from the Association of Investment Companies. In its results for the financial year to 31 March, the fund reported its operative NAV, which reflects the fair value of the music catalogues as per an independent valuation, was $1.9153, up 3.6% over the year. ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
